Blood Pressure Drug Recall Expands Again; Meds May Be Tainted With Cancer-Causing Chemical
(CNN) — The US Food and Drug Administration says another heart medicine is being voluntarily recalled after tests showed that it was tainted with a potential cancer-causing chemical.
The recall includes one lot of Sandoz’s losartan potassium hydrochlorothiazide 100 milligram/25 milligram tablets with the lot number JB8912. Patients use these drugs to keep their high blood pressure in check.
The drug is being recalled because the active ingredient has tested positive for N-Nitrosodiethylamine or NDEA, a suspected human and animal carcinogen that is used in gasoline as a stabilizer for industry materials and as a...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 12, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News Local TV Valsartan Source Type: news
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)
Sandoz Inc. is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. This product is being recalled due to the trace amount of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Losartan, USP manufactured by Zhejiang Huahai Pharmaceutical Co. Ltd. Sandoz Inc. Losartan Potassium Hydrochlorothiazide product is manufactured by Lek Pharmaceuticals dd, Ljubljana, Slovenia. This impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinoge...
Source: Food and Drug Administration - November 9, 2018 Category: Food Science Source Type: news
Diovan HCT (Valsartan and Hydrochlorothiazide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 3, 2018 Category: Drugs & Pharmacology Source Type: news
Drug Recalls: Accord Hydrochlorothiazide and Children's Advil Suspension Bubble Gum Flavored
Label Mix-up Spurs Recall of Accord Blood Pressure Meds
One lot of high blood pressure medication is being recalled after a labeling mix-up, Accord Healthcare Inc. says.
The recall is for 100-count bottles of hydrochlorothiazide tablets USP, 12.5... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 29, 2018 Category: General Medicine Source Type: news
RECALL: Blood Pressure Meds Contain Wrong Drug
Accord Healthcare has recalled one lot of 12.5-milligram hydrochlorothiazide tablets because the 100-count bottle was discovered to contain 100 spironolactone tablets. (Source: WebMD Health)
Source: WebMD Health - August 29, 2018 Category: Consumer Health News Source Type: news
Label Mix-Up Spurs Recall of Accord Blood Pressure Meds
WEDNESDAY, Aug. 29, 2018 -- One lot of high blood pressure medication is being recalled after a labeling mix-up, Accord Healthcare Inc. has announced.
The recall is for 100-count bottles of hydrochlorothiazide tablets USP, 12.5 mg, lot PW05264. One... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 29, 2018 Category: Pharmaceuticals Source Type: news
Blood Pressure Drug Recalled For Possible Life-Threatening Label Error
(CBS Local) – A potentially life-threatening label mix-up has led to a nationwide recall of a high blood pressure medication, according to the U.S. Food and Drug Administration.
Accord Healthcare Inc. is voluntarily recalling one lot of 12.5 mg hydrochlorothiazide tablets after a 100-count bottle of the drug was found to contain 100 tablets of another drug, spironolactone.
Accord Healthcare is recalling some bottles of Hydrochlorothiazide tablets USP, 12.5 mg, which is prescribed for high blood pressure, because they may contain the wrong pills. Photo Credit- ACCORD HEALTHCARE
Both medications are used to treat ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 29, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News blood pressure FDA Local TV Recall talkers Source Type: news
A High Blood Pressure Medication Is Being Recalled After a Potentially ‘Life-Threatening’ Labeling Mistake
A potentially “life-threatening” labeling mix-up spurred a nationwide recall of a high blood pressure medication, the Food and Drug Administration (FDA) announced.
Accord Healthcare is voluntarily recalling a single lot of 12.5-milligram hydrochlorothiazide tablets, after a pharmacy reported finding a 100-count bottle that actually contained spironolactone tablets, according to the FDA. The rest of the lot (PW05264) has been recalled due to the “potential mix-up of labeling,” but Accord says the remainder of its drugs are unaffected.
Both hydrochlorothiazide and spironolactone can be used to treat ...
Source: TIME: Health - August 29, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Recalls Source Type: news
Accord Healthcare Inc. Issues Voluntary Nationwide Recall of Hydrochlorothiazide Tablets USP 12.5 Mg Due to Labeling Mix-up
A 100 count bottle of Hydrochlorothiazide Tablets USP 12.5 mg has been found to contain 100 Spironolactone Tablets USP 25 mg. Since the individual lot, PW05264, of the product is involved in a potential mix-up of labeling, Accord is recalling this individual lot from the market. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 28, 2018 Category: Food Science Source Type: news
